Position in AKTS
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$2,385
New position
Shares Held
74
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 10 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026HM PAYSON & CO holds $1,342,005 across 18 Biotechnology names. AKTS ranks #11 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,052 | $1,019,289 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
2,320 | $126,532 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
105 | $65,471 | |
| 4 | RCUS |
Arcus Biosciences, Inc.
|
1,700 | $52,411 | |
| 5 | ICCC |
Immucell Corp /De/
|
4,000 | $40,200 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
50 | $9,364 | |
| 7 | DBVT |
DBV Technologies S.A.
|
420 | $6,888 | |
| 8 | PRTA |
Prothena Corp Public Ltd Co
|
600 | $5,874 |
All Filings in AKTS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,385 | 74 | Shares | Other | 2026-07-17 | |
| No filing history on record for this holder in this stock. | ||||||